TickerFacts.

A business in context

RLAY research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-07 · 0001193125-26-418096

  2. 4 · Ownership change

    Report date 2026-10-06 · 0001193125-26-418094

  3. 4 · Ownership change

    Report date 2026-09-08 · 0001193125-26-386473

  4. 4 · Ownership change

    Report date 2026-09-08 · 0001193125-26-386464

  5. 4 · Ownership change

    Report date 2026-09-08 · 0001193125-26-386455

  6. 4 · Ownership change

    Report date 2026-08-25 · 0001493152-26-040513

  7. 4 · Ownership change

    Report date 2026-08-26 · 0001193125-26-374645

  8. 4 · Ownership change

    Report date 2026-08-17 · 0001193125-26-355502

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338056

  10. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338013 · Items 1.01,2.02,9.01

  11. 8-K · Current report

    Report date 2026-06-09 · 0001193125-26-263873 · Items 5.03,5.07,9.01

  12. 8-K · Current report

    Report date 2026-05-20 · 0001193125-26-234862 · Items 1.01,9.01

  13. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-229770 · Items 7.01,8.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-206454

  15. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-206398 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-09 · 0001193125-26-186929

  17. 8-K · Current report

    Report date 2026-04-27 · 0001193125-26-179404 · Items 7.01,8.01,9.01

  18. 8-K · Current report

    Report date 2026-03-16 · 0001193125-26-107312 · Items 7.01,8.01,9.01

  19. 8-K · Current report

    Report date 2026-03-06 · 0001193125-26-102178 · Items 5.03,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076739

  21. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-076617 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-02-03 · 0001193125-26-034422 · Items 7.01,8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269601

  24. 8-K · Current report

    Report date 2025-11-04 · 0001193125-25-269536 · Items 2.02,5.02,7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105054

  26. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-105022 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-06-08 · 0001193125-25-139146 · Items 5.02,9.01

  28. 8-K · Current report

    Report date 2025-06-06 · 0001193125-25-137162 · Items 5.07

  29. 8-K · Current report

    Report date 2025-06-03 · 0001193125-25-134908 · Items 1.01,1.02

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-063553

  31. 8-K · Current report

    Report date 2025-05-05 · 0000950170-25-063539 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-06-06 · 0000950170-25-057333

  33. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-027756

  34. 8-K · Current report

    Report date 2025-02-26 · 0000950170-25-027733 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-01-13 · 0000950170-25-004586 · Items 7.01,9.01

  36. 8-K · Current report

    Report date 2024-12-11 · 0000950170-24-135207 · Items 7.01,8.01,9.01

  37. SC 13G/A · Ownership disclosure

    0000080255-24-001461

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122332

  39. 8-K · Current report

    Report date 2024-11-06 · 0000950170-24-122297 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2024-09-09 · 0001193125-24-217296 · Items 1.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 14 transaction rows14SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

16 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-09
Bergstrom Donald AS · Sale
Disposed
Common Stock8530.018.97
2026-09-08
2026-09-09
Catinazzo ThomasS · Sale
Disposed
Common Stock17717.018.94
2026-09-08
2026-09-09
Patel SanjivS · Sale
Disposed
Common Stock48199.018.94
2026-08-26
2026-08-28
Rahmer PeterS · Sale
Disposed
Common Stock4508.020.03
2026-08-25
2026-08-28
SB INVESTMENT ADVISERS (UK) LTD; SOFTBANK VISION FUND (AIV M2) L.P.; SVF Pauling (Cayman) LtdS · Sale
Disposed
Common Stock6000000.019.4
2026-08-17
2026-08-18
Patel SanjivS · Sale
Disposed
Common Stock48199.020.33
2026-08-14
2026-08-18
Catinazzo ThomasS · Sale
Disposed
Common Stock17717.019.74
2026-07-28
2026-07-30
Catinazzo ThomasS · Sale
Disposed
Common Stock1459.018.61
2026-07-28
2026-07-30
Rahmer PeterS · Sale
Disposed
Common Stock748.018.61
2026-07-28
2026-07-30
Bergstrom Donald AS · Sale
Disposed
Common Stock2237.018.61
2026-07-07
2026-07-08
Patel SanjivS · Sale
Disposed
Common Stock48199.019.58
2026-07-06
2026-07-08
Bergstrom Donald AS · Sale
Disposed
Common Stock8660.018.71
2026-07-06
2026-07-08
Catinazzo ThomasS · Sale
Disposed
Common Stock17717.018.69
2026-06-30
2026-07-08
Patel SanjivA · Grant / award
Acquired
Common Stock3056.06.95
2026-06-30
2026-07-02
Rahmer PeterA · Grant / award
Acquired
Common Stock3056.06.95
2026-06-30
2026-07-02
Rahmer PeterS · Sale
Disposed
Common Stock50000.019.09

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001812364Relay Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Relay Therapeutics · alias · wikidata

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$10.01M$10.75M
2023-12-31$25.55M$28.25M
2022-12-31$1.38M$1.59M
2021-12-31$3.03M$3.77M
2020-12-31$82.65M$107.60M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗